Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT07600801
This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Boston, Massachusetts, 02114, United States
This is a non-therapeutic study that will enroll individuals who have a family history of lung cancer. During the study, participants will provide questionnaire responses regarding their personal medical history, family lung cancer history, and exposures along with contributing images from at least one previously obtained CT chest scan. The images and data collected will be analyzed by an image-based deep learning model (Sybil). Sybil is a type of artificial intelligence model that has been shown to accurately predict individuals' future risk of lung cancer based solely on images from a CT Chest scan, but it is unknown if it works well in people with a family history of lung cancer. It is expected that 2,250 will take part in this research study.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Previously obtained computed tomography scan
Image-based deep learning model
Time frame: From date of receival of retrospective CT scan for up to 2 years.
We will estimate future lung cancer diagnoses using the area under the receiver operating curve (AUROC).
Time frame: From receival of retrospective CT scan for up to 2 years.
We will compare the distribution of Sybil scores between participants in the LEGACY study and National Lung Screening Trial.
Time frame: From receival of retrospective CT scan for up to 2 years.
We will estimate the incidence of lung cancer in the LEGACY population.
Time frame: From receival of retrospective CT scan for up to 2 years.
We will estimate the incidence, prevalence, and characteristics of lung nodules in the LEGACY population.
Contact information is provided by the study sponsor or research team.
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07685028
Family History of Lung Cancer, Lung Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07135882
Bronchial Neoplasms, Carcinoma
Gold Coast, Queensland, Australia
View Trial DetailsNCT07738172
Bronchial Neoplasms, Carcinoma, Bronchogenic
Taipei, Taipei City, Taiwan
View Trial DetailsNCT07723495
Head and Neck Neoplasms, Lung Diseases
Detroit, Michigan, United States
View Trial Details